ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HTGMQ HTG Molecular Diagnostics Inc (CE)

0.0025
0.00 (0.00%)
May 09 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 597
Bid Price
Ask Price
News -
Day High 0.0025

Low
0.0013

52 Week Range

High
0.66

Day Low 0.0025
Company Name Stock Ticker Symbol Market Type
HTG Molecular Diagnostics Inc (CE) HTGMQ OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0025 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0025 0.0025 0.0025 0.0025 0.0025
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1 597 $ 0.0025 $ 1 - 0.0013 - 0.66
Last Trade Time Type Quantity Stock Price Currency
15:55:07 597 $ 0.0025 USD

HTG Molecular Diagnostics Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.54k 2.21M - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HTG Molecular Diagnostics (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HTGMQ Message Board. Create One! See More Posts on HTGMQ Message Board See More Message Board Posts

Historical HTGMQ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00250.00250.00150.00187352,6630.000.00%
1 Month0.00150.00250.00150.00179711,8420.00166.67%
3 Months0.010.010.00130.00549143,376-0.0075-75.00%
6 Months0.00130.340.00130.00365313,9450.001292.31%
1 Year0.410.660.00130.356309312,539-0.4075-99.39%
3 Years0.410.660.00130.356309312,539-0.4075-99.39%
5 Years0.410.660.00130.356309312,539-0.4075-99.39%

HTG Molecular Diagnostics (CE) Description

HTG's mission is to advance the promise of precision medicine through innovative transcriptome-wide profiling technology designed to accelerate the development of diagnostics and hasten the discovery of novel drug candidates to effect lifechanging outcomes. The company's proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery.

Your Recent History

Delayed Upgrade Clock